Rui Avelar

Chief Tech/Sci/R&D Officer at EVOLUS, INC.

Net worth: 2 M $ as of 31/07/2026

64 year

87 connections

Health Technology

Consumer Services

Electronic Technology

Profile

Rui Avelar is currently Chief Medical Officer, Head-Research & Development at Evolus, Inc. since 2018.
Formerly, Dr. Avelar was Chief Medical Officer at AEON Biopharma Sub, Inc. from 2014 to 2018 and Chief Medical Officer at Allergan Medical Optics from 2011 to 2013.
Dr. Avelar earned a doctorate from the University of Toronto in 1989.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
EVOLUS, INC. 0.6%	17/04/2026	388,999 ( 0.6% )	2 M $	31/07/2026

Rui Avelar active positions

Companies	Position	Start
EVOLUS, INC.	Chief Tech/Sci/R&D Officer	01/01/2014

All active positions of Rui Avelar

Former positions of Rui Avelar

Companies	Position	End
AEON Biopharma Sub, Inc. AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales pharmaceuticals	Chief Tech/Sci/R&D Officer	01/02/2018
Allergan Medical Optics	Chief Tech/Sci/R&D Officer	01/12/2013

See the detail of Rui Avelar's experience

Training of Rui Avelar

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rui Avelar's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Evolus, Inc. Evolus, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurotoxins	Health Technology
University of Toronto University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Allergan Medical Optics	Electronic Technology
AEON Biopharma Sub, Inc. AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales pharmaceuticals	Health Technology